ClinConnect ClinConnect Logo
Search / Trial NCT06912776

Novel Visual Education Tool to Improve Recognition and Reporting of Postpartum Urgent Maternal Warning Signs

Launched by NORTHWESTERN UNIVERSITY · Apr 2, 2025

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Pregnancy Postpartum Nulliparus

ClinConnect Summary

This clinical trial is looking to create a new visual education tool that helps women recognize and report important warning signs after giving birth. These signs are critical for ensuring the health and safety of new mothers, and the aim is to use clear and simple images to make these signs easier to understand. The study will focus on women who have recently given birth, ensuring that the information is accessible to those with different levels of health knowledge.

To be eligible for this study, participants must be women who have recently given birth (postpartum), are over 18 years old, and speak English. Unfortunately, women with certain serious health complications or those who have difficulty seeing or hearing will not be able to participate. If you join the study, you can expect to learn about these important warning signs in a way that is straightforward and easy to grasp. This trial is not yet recruiting participants, but it promises to provide valuable information for new mothers in the future.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Postpartum women
  • Nulliparity
  • Age \>18 years of age
  • English speaking patients
  • Exclusion Criteria:
  • Inability to provide informed written consent
  • Refusal to participate in all study-related procedures
  • Patients not fluent in English
  • Patients with current or history of serious peripartum complications and/or events - such as DVT, PE, peripartum cardiomyopathy, etc. (in which the patient may have received more than standard clinical counseling)
  • Patient with comorbidities that potentially require anticoagulation i.e. coagulopathies and may be more prone to DVTs
  • Patients with uncorrected visual or hearing impairment
  • Healthcare providers (in which patients will have significant background knowledge)

About Northwestern University

Northwestern University is a prestigious academic institution renowned for its commitment to advancing medical research and improving patient care through innovative clinical trials. With a robust infrastructure that supports interdisciplinary collaboration, Northwestern leverages its expertise in various fields, including medicine, engineering, and social sciences, to drive groundbreaking studies. The university is dedicated to adhering to the highest ethical standards and regulatory compliance, ensuring that all clinical trials are conducted with the utmost integrity and focus on participant safety. Through its Clinical Trials Office, Northwestern aims to translate scientific discoveries into effective therapies, ultimately enhancing health outcomes and contributing to the broader medical community.

Locations

Chicago, Illinois, United States

Patients applied

0 patients applied

Trial Officials

Kaitlyn Neumann, MD

Principal Investigator

Northwestern University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported